Healthcare data firm SK&A sold to Cegedim
SK&A holds contact and profiling information on more than two million healthcare practitioners, which Cegedim plans to use to bolster its OneKey database services in the US.
Dave Escalante, SK&A’s president and CEO, will continue to lead the business in his new role of vice president of data and information solutions.
Cegedim Dendrite is part of the Cegedim Group, which has headquarters in France. Previous acquisitions include patient data firm Hospital Marketing Services and pharma intelligence firm Nomi.
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
1 Comment
Ishwar
15 years ago
I believe that Cegedim could be a major contender as a data vendor, but I feel that general information like prescriber information should be readily available to pharma companies via a congregated effort by them which would bring doen their data acquisition costs significantly.
Like Reply Report